Pelvic exenteration in gynecologic cancer: complications and oncological outcome

Table 5 Oncological outcome

Mortality [n (%)]
< 30 days	0 (0)
> 30 days	2 (9)
Follow-up [Mean (range)]	18.5 (1–71)
OS (%)
6 months	85
12 months	70.6
24 months	54.4
48 months	41.6
DFS (%)
6 months	80
12 months	61.1
24 months	56.2
48 months	30.8
Disease status at last follow-up [n (%)]
NED	14 (61)
AWD	1 (4)
DOD	8 (35)
DOC	0 (0)
Lost in follow-up	0 (0)

OS overall survival, DFS disease-free survival, NED no evidence of disease, AWD alive with disease, DOD dead of disease: dead for other circumstances